Cover Image
市場調查報告書

瘀傷/挫傷:全球臨床實驗檢討

Bruise (Contusion) Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 296021
出版日期 內容資訊 英文 40 Pages
訂單完成後即時交付
價格
Back to Top
瘀傷/挫傷:全球臨床實驗檢討 Bruise (Contusion) Global Clinical Trials Review, H1, 2017
出版日期: 2017年05月31日 內容資訊: 英文 40 Pages
簡介

本報告提供全球瘀傷/挫傷治療藥臨床實驗的相關調查,彙整各地區,各階段,各狀態臨床實驗趨勢,正在開發的藥物概要等,為您概述為以下內容。

目錄

簡介

各地區臨床實驗

  • 各國家臨床實驗
    • 亞太地區的前幾名國家
    • 歐洲的前幾名國家
    • 北美的前幾名國家
    • 中東·非洲的前幾名國家
    • 中南美的前幾名國家

G7各國臨床實驗

E7各國臨床實驗

各階段臨床實驗

各狀態臨床實驗

一定期間內募集的實驗對象

贊助商各類型臨床實驗

主要的贊助商

  • 瘀傷/挫傷臨床實驗參與計劃的主要企業

主要藥物

臨床實驗簡介

  • 主要企業
    • Reckitt Benckiser Group Plc
    • Kythera Biopharmaceuticals, Inc.
    • 久光製藥
    • Chiesi S. p. A.
    • Chiesi Farmaceutici SpA
  • 大學·機關·醫院
    • Center for Clinical and Cosmetic Research
    • Golestan University of Medical Sciences
    • Nanjing University
    • Mayo Clinic
    • North West London Hospitals NHS Trust
    • Hamilton Health Sciences
    • University Hospitals of Cleveland

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's clinical trial report, "Bruise (Contusion) Global Clinical Trials Review, H1, 2017" provides an overview of Bruise (Contusion) clinical trials scenario. This report provides top line data relating to the clinical trials on Bruise (Contusion). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Clinical Trials by G7 Countries: Proportion of Bruise (Contusion) to Dermatology Clinical Trials 13
  • Clinical Trials by Phase in G7 Countries 14
  • Clinical Trials in G7 Countries by Trial Status 15
  • Clinical Trials by E7 Countries: Proportion of Bruise (Contusion) to Dermatology Clinical Trials 16
  • Clinical Trials by Phase in E7 Countries 17
  • Clinical Trials in E7 Countries by Trial Status 18
  • Clinical Trials by Phase 19
  • Clinical Trials by Trial Status 20
  • Clinical Trials by End Point Status 21
  • Subjects Recruited Over a Period of Time 22
  • Clinical Trials by Sponsor Type 23
  • Prominent Sponsors 24
  • Top Companies Participating in Bruise (Contusion) Therapeutics Clinical Trials 25
  • Clinical Trial Profile Snapshots 26

Appendix 37

  • Abbreviations 37
  • Definitions 37
  • Research Methodology 38
  • Secondary Research 38
  • About GlobalData 39
  • Contact Us 39
  • Source 40

List of Tables

List of Tables

  • Bruise (Contusion) Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Bruise (Contusion) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Bruise (Contusion) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 9
  • Bruise (Contusion) Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
  • Bruise (Contusion) Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
  • Bruise (Contusion) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 12
  • Proportion of Bruise (Contusion) to Dermatology Clinical Trials, G7 Countries (%), 2017* 13
  • Bruise (Contusion) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
  • Bruise (Contusion) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
  • Proportion of Bruise (Contusion) to Dermatology Clinical Trials, E7 Countries (%), 2017* 16
  • Bruise (Contusion) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17
  • Bruise (Contusion) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Bruise (Contusion) Therapeutics, Global, Clinical Trials by Phase, 2017* 19
  • Bruise (Contusion) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 20
  • Bruise (Contusion) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 21
  • Bruise (Contusion) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 22
  • Bruise (Contusion) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 23
  • Bruise (Contusion) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 24
  • Bruise (Contusion) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 25

List of Figures

List of Figures

  • Bruise (Contusion) Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Bruise (Contusion) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Bruise (Contusion) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
  • Bruise (Contusion) Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
  • Proportion of Bruise (Contusion) to Dermatology Clinical Trials, G7 Countries (%), 2017* 13
  • Bruise (Contusion) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
  • Bruise (Contusion) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
  • Proportion of Bruise (Contusion) to Dermatology Clinical Trials, E7 Countries (%), 2017* 16
  • Bruise (Contusion) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17
  • Bruise (Contusion) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Bruise (Contusion) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 19
  • Bruise (Contusion) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 20
  • Bruise (Contusion) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 21
  • Bruise (Contusion) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 22
  • Bruise (Contusion) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 23
  • Bruise (Contusion) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 24
  • Bruise (Contusion) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 25
  • GlobalData Methodology 38
Back to Top